CAM
IMVT icon

Concorde Asset Management’s Immunovant IMVT Stock Holding History

Concorde Asset Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-16,725
Closed -$297K – 114
2022
Q4 		$297K Buy
+16,725
New +$297K 0.26% 94